Track: Dyslipidemia and Risk factors

Heart 2023 Conference - Dyslipidemia and Risk factors

Sub-Track:

Dyslipidemia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027 is a recent study from Transparency Market Research (TMR). The report estimates that the market for pharmaceuticals to treat dyslipidemia was worth US$ 11.8 billion in 2018 and would grow at a CAGR of 3.5% from 2019 to 2027. From 2019 to 2027, rising illness awareness thanks to promotional campaigns and an increase in the prevalence of people with abnormal cholesterol and triglyceride levels will be the key market drivers for dyslipidemia medications worldwide.

SUBTOPICS:

· Epidemiology of cardiovascular diseases and risk factors

· Epidemiology of dyslipidemias

· Diabetes, insulin sensitivity and resistance

· Adipose tissue homeostasis

· Inherited dyslipidemias

· Gender and cardiovascular risk

· Environmental risk factors

· Novel risk factors and biomarkers

· Epidemiology of socioeconomic and psychosocial risk factors

· Coagulation

· Gut microbiome

· Gene editing technology

· Genomics, GWAS and population genetics; Mendelian randomization

· Epigenetics and microRNA

· Gene-Environment interactions

Related Societies: American Heart Association USA; Japanese Circulation Society; British Junior Cardiologists Association, UK; Cardiac Society of Australia and New Zealand Sydney; Cardiology Society Los Angeles; World Society of Arrhythmias Beijing; The Pan-African Society of Cardiology (PASCAR) Algeria; Philippine Heart Association Manila; Asian Society for Cardiovascular Surgery (ASCVS) Fukuoka. Brazilian Society of Cardiology, Caribbean Cardiac Society, SOLACI Latin American Society of Interventional Cardiology, Colombian Society of Cardiology, Costa Rican Association of Cardiology

Related Hospitals: Cleveland Clinic, Mayo Clinic, New York-Presbyterian Hospital, Cedars-Sinai Medical Center, Massachusetts General Hospital, NewYork-Presbyterian Hospital-Columbia and Cornell, Johns Hopkins Hospital, NYU Langone Hospitals, Northwestern Memorial Hospital, Hospitals of the University of Pennsylvania-Penn Presbyterian, Mount Sinai Hospital, University of Michigan Hospitals and Health Centers, Duke University Hospital, Brigham and Women's Hospital, Barnes-Jewish Hospital, UCLA Medical Center, Stanford Health Care-Stanford Hospital, Heart Hospital Baylor Plano, Houston Methodist Hospital, Loyola University Medical Center, NYU Langone Medical Center, UPMC Presbyterian Shadyside, Scripps La Jolla Hospitals, Ohio State University Wexner Medical Center, UCSF Medical Center, Sentara Norfolk General Hospital-Sentara Heart Hospital, Texas Heart Institute at Baylor St. Luke's Medical Center, Beaumont Hospital-Royal Oak, Minneapolis Heart Institute at Abbott Northwestern Hospital, Vanderbilt University Medical Center, Memorial Hermann-Texas Medical Center, The University of Alabama at Birmingham Hospital, University of Colorado Hospital, St. Francis Hospital.

3rd International Conference on Cardiology (Hybrid Event)

November 30- December 01, 2023 | Dubai, UAE

Track: Dyslipidemia and Risk factors

Sub-Track:

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at